首页> 外文OA文献 >In-vitro Relationship between Protein-binding and Free Drug Concentrations of a Water-soluble Selective Beta-adrenoreceptor Antagonist (Atenolol) and Its Interaction with Arsenic
【2h】

In-vitro Relationship between Protein-binding and Free Drug Concentrations of a Water-soluble Selective Beta-adrenoreceptor Antagonist (Atenolol) and Its Interaction with Arsenic

机译:水溶性选择性β-肾上腺素受体拮抗剂(Atenolol)的蛋白质结合与游离药物浓度之间的体外关系及其与砷的相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The degree of binding of a drug to plasma proteins has a marked effect on its distribution, elimination, and pharmacological effect since only the unbound fraction is available for distribution into extra-vascular space. The protein-binding of atenolol was measured by equilibrium dialysis in the bovine serum albumin (BSA). Free atenolol concentration was increased due to addition of arsenic which reduced the binding of the compounds to BSA. During concurrent administration, arsenic displaced atenolol from its high-affinity binding Site I, and free concentration of atenolol increased from 4.286±0.629% and 5.953±0.605% to 82.153±1.924% and 85.486±1.158% in absence and presence of Site I probe respectively. Thus, it can be suggested that arsenic displaced atenolol from its binding site resulting in an increase of the free atenolol concentration in plasma.
机译:药物与血浆蛋白的结合程度对其分布,消除和药理作用具有显着影响,因为只有未结合的部分可用于分布到血管外空间。通过平衡透析在牛血清白蛋白(BSA)中测量阿替洛尔的蛋白质结合。游离阿替洛尔浓度的增加归因于砷的添加,从而降低了化合物与BSA的结合。在同时给药期间,砷在其高亲和力结合位点I上取代了替诺洛尔,并且在没有和存在Site I探针的情况下,游离阿替洛尔的浓度从4.286±0.629%和5.953±0.605%增至82.153±1.924%和85.486±1.158%分别。因此,可以暗示砷将阿替洛尔从其结合位点置换,导致血浆中游离阿替洛尔浓度增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号